Moleculin Biotech, Inc. - 8-K Filing
Moleculin Biotech secures Australian patent for Annamycin formulation technology (Items: 7.01 of this Current Report on Form 8-K, including Exhibit 99)
Tickers: $MBRX
More Regulatory news
- NVIDIA CORP - 8-K Filing
- COVENANT LOGISTICS GROUP, INC. - 8-K Filing
- CuriosityStream Inc. - 10-Q Filing
- Star Equity Holdings, Inc. - 8-K Filing
- DeFi Development Corp. - 10-Q Filing
- BALTIC INTERNATIONAL USA INC - 10-Q Filing
- Forbright, Inc. - 8-K Filing
- Boxlight Corp - 8-K Filing
- CuriosityStream Inc. - 8-K Filing
- BORGWARNER INC - 8-K Filing